These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 14712413)
1. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?]. Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413 [TBL] [Abstract][Full Text] [Related]
2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study. Kollmar R; Henninger N; Bardutzky J; Schellinger PD; Schäbitz WR; Schwab S Exp Neurol; 2004 Nov; 190(1):204-12. PubMed ID: 15473993 [TBL] [Abstract][Full Text] [Related]
4. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model. Lu HT; Zhao JG; Li MH; Li YD Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456 [TBL] [Abstract][Full Text] [Related]
5. The molecular basis of thrombolysis and its clinical application in stroke. Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866 [TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model. Collen D; Stassen JM; De Cock F Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288 [TBL] [Abstract][Full Text] [Related]
8. A new rat model of thrombotic focal cerebral ischemia. Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis. Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987 [TBL] [Abstract][Full Text] [Related]
10. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
11. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906 [TBL] [Abstract][Full Text] [Related]
12. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
13. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat. Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970 [TBL] [Abstract][Full Text] [Related]
14. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis. Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment. Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke. Daffertshofer M; Huang Z; Fatar M; Popolo M; Schroeck H; Kuschinsky W; Moskowitz MA; Hennerici MG Neurosci Lett; 2004 May; 361(1-3):115-9. PubMed ID: 15135907 [TBL] [Abstract][Full Text] [Related]
17. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
18. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976 [TBL] [Abstract][Full Text] [Related]
19. [Intravenous thrombolysis with rt-PA in stroke: experience of the French military hospital of Toulon from September 2003 to June 2009]. Faivre A; Sagui E; Canini F; Wybrecht D; Bounolleau P; Grapperon J; Alla P; Valance J Rev Neurol (Paris); 2010 Nov; 166(11):909-20. PubMed ID: 20452634 [TBL] [Abstract][Full Text] [Related]
20. MRI evaluation of treatment of embolic stroke in rat with intra-arterial and intravenous rt-PA. Jiang Q; Zhang ZG; Zhang L; Ding GL; Li L; Ewing JR; Lu M; Whitton P; Hu J; Li QJ; Zhang RL; Chopp M J Neurol Sci; 2004 Sep; 224(1-2):57-67. PubMed ID: 15450772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]